Figure 3.

Serum (bilirubin) as a multiple of the upper limit of the reference range in nine ESS with CH, at diagnosis (before prednisolone treatment), first recheck (2–4 weeks after starting 1–2 mg/kg/day prednisolone) and at tapering doses of prednisolone. A significant difference was identified between the values at diagnosis and first recheck; however, due to variability of dosing, the authors did not assess statistical differences between the remaining prednisolone doses. Each coloured shape represents an individual patient. CH, chronic hepatitis; EOD, Every Other Day; ESS, English springer spaniels.